Drupal.behaviors.print = function(context) {window.print();window.close();}>
Driven by Product Revenues, BG Medicine's Q4 Revenues Spike 90 Percent
March 08, 2012
Driven by Product Revenues, BG Medicine's Q4 Revenues Spike 90 Percent
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
BG Medicine's Heart Test Powers 175 Percent Revenue Growth in Q4
March 13, 2013 / GenomeWeb Daily News
BG Medicine Prices Public Offering, Reaches Stock Purchase Agreement
January 25, 2013 / GenomeWeb Daily News
BG Medicine Reports 47 Percent Q4 Revenue Drop
March 17, 2011 / GenomeWeb Daily News
Galectin-3 Included as Biomarker for Heart Failure in ACCF/AHA 2013 Guidelines
June 14, 2013 / ProteoMonitor
BG Medicine Fails to Meet Listing Requirement, Nasdaq Warns Firm
May 20, 2013 / GenomeWeb Daily News